Unifex

Quick links to important sections

Unifex

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Unifex

Quick Facts

Property Description
Active Ingredients Cephalexin (Antibiotic) and Probenecid (Enhancer)
Form Tablet, Capsule, Oral suspension
Pharmacological Class Cephalosporin antibiotic (First-Generation) and Uricosuric agent
Common Use Anti-infective agent against susceptible bacteria
Origin Synthetic
RX Status Prescription-only

Unifex is a prescription-only combination medicine specifically formulated as an enhanced anti-infective agent intended for oral administration. The drug’s unique composition, consisting of two distinct synthetic compounds, is designed to provide a higher and more sustained level of antibacterial activity for the treatment of susceptible bacterial infections.

Core Identity and Pharmacological Class

The core identity of Unifex is defined by its two active components: Cephalexin, the therapeutic agent, and Probenecid, the pharmacokinetic support. Cephalexin is an established first-generation cephalosporin antibiotic, a class known for its bactericidal action achieved by inhibiting the synthesis of the bacterial cell wall. This mechanism is clinically recognized for its ability to eliminate targeted bacteria.

Composition and Unique Purpose

The medicine contains Cephalexin alongside Probenecid, a compound typically categorized as a uricosuric agent. In the Unifex formulation, Probenecid is included strictly for pharmacokinetic enhancement. This unique feature differentiates it from standard single-agent cephalosporin treatments. Probenecid achieves this by competitively inhibiting the renal tubular secretion of the antibiotic through the kidney, which is a verified mechanism of action. The general purpose of this combination is to ensure the Cephalexin maintains elevated and sustained plasma concentrations for an extended period, maximizing its effectiveness against bacterial infections.

What side effects are possible with Unifex?

Possible side effects and safety information

The safety profile for Unifex (Cephalexin/Probenecid) is primarily based on the documented risks associated with its cephalosporin antibiotic component, as outlined in official regulatory labeling.

Adverse Reaction Classification

Adverse reactions are classified by the physiological system affected. The Gastrointestinal Disorders category includes the most frequently reported effects, such as Diarrhea, Nausea, Vomiting, Dyspepsia, and Abdominal Pain. Other system-organ classes involved include Skin and Subcutaneous Tissue Disorders (e.g., rash, urticaria), Nervous System Disorders (e.g., headache, dizziness), and Hepatobiliary Disorders.

Serious Adverse Reactions and Key Safety Constraints

Regulatory documents highlight the potential for serious adverse reactions. These include severe hypersensitivity events like Anaphylaxis, Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN). A major concern is Clostridium difficile-Associated Diarrhea (CDAD), which can occur during or up to two months after administration. Safety restrictions note that the medicine is contraindicated in patients with a known hypersensitivity to cephalosporins.

Population-Specific Safety Notes

The combination product requires specific caution for certain patient groups. Individuals with renal impairment are at increased risk due to the Probenecid component, which elevates and sustains cephalexin levels. This may increase the potential for adverse effects, including seizures. Older adults may also require closer safety monitoring due to the higher likelihood of age-related decreases in kidney function. Risks such as superinfection are documented as being associated with the prolonged use of the antibiotic component.

Overdose and Emergency Response

The official regulatory profile for Unifex (Cephalexin/Probenecid) outlines the specific clinical manifestations and mandated emergency actions required in case of a suspected overdose. Documented overdose presentations commonly involve the gastrointestinal system, resulting in signs such as nausea, vomiting, diarrhea, and epigastric distress. Furthermore, effects on the central nervous system may be present, including documented reports of drowsiness, confusion, agitation, or hallucinations. The occurrence of bloody urine (haematuria) is also listed as a clinical sign associated with overdose.

The official labeling details severe, life-threatening outcomes, most notably the potential for convulsions (seizures), breathing problems, and organ injury, specifically toxic nephropathy. Due to the severity of these documented outcomes and the regulatory statement that no specific antidote is known, authorities mandate that any suspected overdose requires immediately seeking medical attention. Individuals must contact emergency services or a poison control center right away, as time is critical. Overdose management is officially described as symptomatic and supportive, necessitating close clinical and laboratory monitoring of renal, hepatic, and haematological functions until the patient is stable. This required monitoring is essential because the labeling also notes a specific risk of heightened seizure potential in patients with pre-existing impaired renal function.

Therapeutic Uses of Unifex

What Unifex Treats: Main Uses and Benefits

Unifex (Cephalexin/Probenecid) is an anti-infective combination used in contexts involving heightened systemic burden where sustained antibiotic activity is appropriate. The medication is applied in addressing susceptible bacterial pathogens, helping to address acute symptoms and contribute to improved comfort. The drug is commonly used for acute bacterial infections of the skin and soft tissue (e.g., cellulitis, abscesses), the respiratory tract (including otitis media), the genitourinary system (e.g., cystitis, pyelonephritis), and bone (e.g., osteomyelitis).


The therapy is relevant for managing symptoms that interfere with daily comfort, such as localized pain, fever, and inflammation associated with active infection. The support provided helps ease the overall symptom burden during these difficult episodes. This formulation is relevant when supportive symptom management is appropriate, particularly across domains involving acute or disruptive symptom patterns.

Quick Fact: Support for Symptoms Related to Systemic Discomfort

Unifex may assist with supporting the management of the underlying bacterial load, which contributes to improved day-to-day comfort by supporting the management of symptoms related to physical discomfort and systemic imbalance. This is particularly relevant in situations involving recurrent or deep-seated infection, where sustained coverage is relevant.

Regulatory References

  1. Official FDA Labeling via NIH DailyMed

Eligibility and Restrictions for Use

Who can and cannot use Unifex?

Unifex (Cephalexin/Probenecid) is a prescription-only combination medicine whose use is strictly defined by the regulatory profile of both active ingredients. Eligibility depends on age, allergy history, and pre-existing medical conditions.

Contraindicated Populations (Must Not Use) Conditional Eligibility (Use with Caution)
Known hypersensitivity to Cephalexin or Probenecid History of penicillin allergy (risk of cross-reactivity)
Allergy to any cephalosporin class antibiotic Markedly impaired renal function or known renal impairment
Pediatric patients less than two years of age Pregnant or breastfeeding women (lack of adequate studies)
Presence of blood dyscrasias History of colitis or severe diarrhea
History of uric acid kidney stones Older adults, often due to potential for age-related kidney issues

The medicine is generally allowed for use in adults and children aged two years and older who do not have any contraindications. Use is not recommended in the presence of known renal impairment due to the Probenecid component, and it requires caution during pregnancy and lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes documented interaction patterns involving the components of Unifex, as specified in regulatory labeling.

Documented Restrictions and Exposure Changes

Co-administration with Salicylates (such as aspirin) is formally contraindicated due to pharmacodynamic antagonism that nullifies the uricosuric action of the Probenecid component. The combination is also not recommended with Dofetilide, as inhibition of clearance significantly increases Dofetilide plasma concentrations. The Probenecid component inhibits the renal tubular secretion of Methotrexate, leading to increased plasma concentrations; dosage reduction is officially required.

The Cephalexin component is documented to increase Metformin plasma C max and AUC. Co-administration with Warfarin carries a documented increased risk of bleeding associated with a fall in prothrombin activity. Furthermore, Probenecid decreases the renal excretion of Conjugated Sulfonamides, leading to increased total plasma levels.

Administration Constraints

Interactions involving Zinc-containing products require a mandatory administration separation: these products must be administered at least 3 hours after the Unifex dose to prevent reduced antibiotic absorption. The combination is also not recommended in individuals with known renal impairment due to the enhanced systemic accumulation of the antibiotic component.

Mechanism of Action

Unifex, containing cefalexin, acts as a bactericidal antimicrobial agent. Its primary biological target is the bacterial cell wall synthesis machinery in susceptible microorganisms, particularly the inner membrane-associated enzymes known as penicillin-binding proteins (PBPs).

The molecule functions as an inhibitor by covalently binding to the active site of PBPs. This binding event prevents the transpeptidation step, which is the final stage of peptidoglycan cross-linking. Peptidoglycan is an essential component providing mechanical strength and rigidity to the bacterial cell wall.

Intracellularly, the interference with PBP function leads to a compromised, structurally weak peptidoglycan layer. This molecular pathway disruption results in the activation of bacterial autolytic enzymes. The downstream cascade involves the loss of cell wall integrity, rendering the cell susceptible to internal osmotic pressure. The system-level physiological consequence of this structural failure is bacterial cell lysis and death.

Dosage and Administration Information

How to Use Unifex

Unifex (Cephalexin/Probenecid) is a prescription medicine formulated for oral administration only, available as tablets, capsules, and an oral suspension. The drug's usage follows a unique pattern specific to its high-concentration formulation, differing significantly from standard multi-day antibiotic schedules.

Dosing and Administration Course

The medicine is prescribed as a single-course treatment, meaning the entire therapy is completed with one administration. This fixed-duration approach is reserved for clinical scenarios that require sustained and elevated systemic antibiotic concentrations, leveraging the combination's unique design. The standard adult regimen involves a fixed, high dose, such as the co-administration of Cephalexin 2 grams and Probenecid 500 mg, administered at one time to complete the course of use.

Procedural Conditions and Adjustments

For proper procedural compliance, the dose may be taken without regard to food. However, the official guidelines explicitly state that the entire dose should be consumed with a full glass of water. If the oral suspension form is used, it must be shaken well prior to measurement and intake. Furthermore, dose adjustment or restriction is required for specific populations, particularly in individuals with reduced kidney function (renal impairment), as both active components rely on the renal system for elimination, which is a mandatory consideration in procedural use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Unifex

Pharmacokinetic Foundation: Understanding Sustained Drug Levels

Research on Unifex was initially focused on its unique two-component design, specifically exploring how Probenecid affects the body's handling of the antibiotic Cephalexin. Studies monitored the drug levels in the bloodstream, primarily using short-term, controlled trials conducted in healthy adult volunteers. These trials examined how quickly the antibiotic was cleared and what the total systemic exposure was over time.

Findings from these foundational trials show patterns related to drug concentration. Research describes that the addition of Probenecid was associated with a sustained presence of Cephalexin in the plasma, and was associated with higher measured concentrations over an extended time compared to the antibiotic used alone. This evidence contributes to the understanding of the scientific basis for this unique formulation.

Evidence for Susceptible Bacterial Infections

Clinical research has evaluated the use of Unifex in conditions characterized by fluctuating or episodic manifestations of infection, such as those affecting the skin, soft tissue, and urinary or respiratory systems. Studies, including comparative randomized controlled trials ( RCTs), research examined patient outcomes related to clinical cure, defined as the absence or reduction of targeted infection-related signs, and outcomes related to physical discomfort. Research also monitored the microbiological cure, exploring whether the targeted bacteria were no longer detectable.

In these trials, findings describe patterns observed in the studies regarding the achievement of clinical and microbiological endpoints during the short treatment period. Non-inferiority trials were designed to investigate if outcomes were comparable to certain other standard antibiotic treatments.

Areas of Research Uncertainty and Study Gaps

Evidence quality varies across studies, with strong data on the pharmacokinetic profile but more limited data from large, dedicated RCTs focused purely on clinical superiority in every infection type. There is limited information for long-term outcomes and recurrence rates. Additionally, a lack of consistent, robust data for the use of the combination in many special populations (pediatric, severe comorbidity) means that clinical decisions in these groups are informed by physician experience and extrapolation from the established PK research, rather than dedicated trial evidence.

Key Studies & References

  1. Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis (ClinicalTrials.gov)
  2. Label: CEPHALEXIN tablet - DailyMed (Regulatory/General Information)

Frequently Asked Questions (FAQ)

Common questions about Unifex (FAQ)

Q: Why do doctors prescribe Unifex instead of other drugs for the same condition?

A: Official studies show that the Probenecid component in Unifex helps sustain and increase the concentration of the antibiotic, Cephalexin, in the bloodstream for a longer duration. This enhanced delivery profile, which is unique to the combination, is the scientific basis for the medicine’s specific formulation.

Q: What is the main difference between Unifex and [Competitor Drug Name]?

A: Unifex is unique because it combines the antibiotic Cephalexin with a second compound, Probenecid. According to official documents, Probenecid is included to slow down the kidney’s process of clearing the antibiotic. This helps maintain higher levels of Cephalexin in the body for an extended time.

Q: How long does it typically take for Unifex to start working, and do you feel the effects immediately?

A: The onset of the drug's activity relates to how quickly the antibiotic component is absorbed. Official pharmacokinetic data indicates that the antibiotic, Cephalexin, typically reaches its maximum measured concentration in the bloodstream within approximately one hour after the dose is administered.

Q: How long does Unifex stay in your system after stopping use?

A: The rate at which the drug is eliminated from the body is a measured parameter in regulatory studies. The compound Probenecid is specifically formulated to extend the half-life of the antibiotic component, which means it stays in the plasma for an extended duration before being fully cleared.

Q: Is it common to feel tired or dizzy when starting Unifex?

A: Official documents list dizziness as a possible side effect that falls under the category of Nervous System Disorders. Information regarding fatigue or tiredness is not consistently highlighted as a commonly reported effect in official patient information.

Q: Can you take Unifex if you are also taking a common pain reliever?

A: Official documents specifically state that Unifex should not be used with Salicylates, such as aspirin. This is because Salicylates can interfere with the Probenecid component. Regulatory sources do not provide comprehensive interaction details for every non-salicylate over-the-counter pain reliever, so the recommendation is to rely on professional sources for clarification.

Q: Is it safe to drink alcohol while using Unifex?

A: Official documents regarding the Probenecid component contain a statement cautioning against the consumption of alcoholic beverages. This is based on findings that excessive alcohol intake may lessen the drug’s intended effects.

Q: Is Unifex listed as a controlled substance?

A: According to regulatory classifications, Unifex is not listed as a controlled substance under the DEA schedule. It is classified as a prescription-only medicine, meaning it requires authorization for use.

Q: What happens if I miss a dose of Unifex?

A: Official documents for the antibiotic component generally recommend taking a missed dose as soon as it is remembered. However, because Unifex is prescribed as a single, complete course of treatment given at one time, it is important that the specific administration instructions provided by the prescriber are followed exactly.

Q: Does Unifex require special monitoring or blood tests?

A: Regulatory documents note that certain pre-existing conditions, like liver or kidney dysfunction, increase the risk of potential adverse effects. If these conditions are present, or if signs of potential adverse reactions develop, laboratory monitoring may be needed to safely manage use.

Q: Is there a generic version of Unifex available?

A: The two active components, Cephalexin and Probenecid, are widely available as generic drug substances. The availability of a specific generic equivalent for the unique Unifex combination product is determined by the local regulatory market status.

Q: What is the official chemical name of the active ingredient in Unifex?

A: The primary antibiotic component, Cephalexin, is defined in regulatory documents by its chemical name: 7-(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid monohydrate. This is how the substance is formally identified in medical and scientific texts.

Q: Does the time of day matter when taking Unifex?

A: Regulatory documents state the full course of therapy is to be administered at one time. There is no specific requirement or mandate in the official prescribing information regarding a preferred time of day for the single administration.

Q: Is Unifex used for any conditions other than the main one listed on the label?

A: The official regulatory documents define the specific scope of use and the indications for which the medicine has been formally studied and approved. This information is limited to discussing only those authorized uses listed on the product label.

Q: What should I do if a side effect seems to be getting worse?

A: For any signs of a serious adverse reaction, such as a severe allergic reaction or severe diarrhea, the situation warrants immediate medical attention. Official patient information suggests contacting a healthcare provider immediately if any side effects worsen or become concerning during the course of administration.

Q: How does Unifex affect the kidneys or liver?

A: Since the drug is processed by the kidneys, the official labeling notes that dose adjustment or restriction is required if a patient has reduced kidney function. Additionally, Hepatobiliary Disorders (liver and bile system issues) are listed as a documented category of potential side effects.

Q: Is there a warning about driving or operating machinery while on Unifex?

A: While a specific administrative warning about operating machinery is not consistently highlighted in regulatory information, official documents do list dizziness as a possible side effect. Dizziness may affect a person's attention and coordination.

Q: What does it mean if Unifex has a 'Boxed Warning'?

A: A Boxed Warning (sometimes called a Black Box Warning) is a formal designation by the FDA used to highlight serious or potentially life-threatening risks associated with a drug. The labeling for Unifex, according to current official documents, does not contain this specific type of warning.

Q: Does Unifex affect fertility in men or women?

A: Studies involving the antibiotic component in animal models have not revealed evidence of impaired fertility. As with many medicines, there are no adequate and well-controlled studies specifically involving human women who are pregnant, so use during pregnancy or lactation requires caution.

Q: Can Unifex be taken with herbal supplements?

A: Official documents specifically warn against co-administration with zinc-containing products. For most other herbal supplements, official regulatory documents state there is limited information available to determine the safety or potential interaction of combining them with the drug.

Q: Can Unifex be split or crushed?

A: The documented administration procedure is that tablets and capsules are intended to be swallowed whole with a drink of water. This is required unless a healthcare professional gives explicit instructions, as this procedural change may affect how the entire dose is absorbed as designed.

Q: Why do some people report that Unifex causes headaches?

A: Headache is listed in official documents as a documented potential side effect, classified under Nervous System Disorders. The underlying biological reason or specific mechanism for why this side effect may occur is typically not provided in patient information materials.

Q: Are there any specific lab tests needed before starting Unifex?

A: Regulatory documents require careful consideration of pre-existing conditions, such as reduced kidney function or blood disorders (blood dyscrasias), before administration. While testing is not explicitly mandated for everyone, laboratory assessment is often necessary to evaluate these existing conditions.

How should Unifex be stored and disposed of?

How to Store and Dispose of Unifex

Official regulatory documents define strict conditions for the storage and disposal of Unifex (Cephalexin/Probenecid) to maintain its stability and ensure safety.

Storage Requirements

Unifex tablets must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The medicine must be kept in a closed container and protected from heat, moisture, and direct light; it is mandatory to keep from freezing.

For the oral suspension form, once mixed, it must be stored in the refrigerator and discarded after 14 days to ensure potency. All forms must be kept out of the reach and sight of children and pets.

️ Disposal Instructions

Unused or expired product should be disposed of using an authorized drug take-back program. If this option is unavailable, the product must be mixed with an undesirable substance, sealed in a container, and placed in the household trash. Unifex is not listed as a medication recommended for flushing down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Unifex found in:

A-Z Index: